SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-008532
Filing Date
2022-05-12
Accepted
2022-05-12 16:06:53
Documents
54
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q armp-20220331x10q.htm   iXBRL 10-Q 1051077
2 EX-31.1 armp-20220331xex31d1.htm EX-31.1 15462
3 EX-31.2 armp-20220331xex31d2.htm EX-31.2 15270
4 EX-32.1 armp-20220331xex32d1.htm EX-32.1 8016
5 EX-32.2 armp-20220331xex32d2.htm EX-32.2 8205
6 GRAPHIC armp-20220331x10q001.jpg GRAPHIC 48974
  Complete submission text file 0001558370-22-008532.txt   4285997

Data Files

Seq Description Document Type Size
7 EX-101.SCH armp-20220331.xsd EX-101.SCH 31627
8 EX-101.CAL armp-20220331_cal.xml EX-101.CAL 32795
9 EX-101.DEF armp-20220331_def.xml EX-101.DEF 144260
10 EX-101.LAB armp-20220331_lab.xml EX-101.LAB 254953
11 EX-101.PRE armp-20220331_pre.xml EX-101.PRE 234377
48 EXTRACTED XBRL INSTANCE DOCUMENT armp-20220331x10q_htm.xml XML 544364
Mailing Address 4503 GLENCOE AVENUE MARINA DEL REY CA 90292
Business Address 4503 GLENCOE AVENUE MARINA DEL REY CA 90292 310-665-2928
Armata Pharmaceuticals, Inc. (Filer) CIK: 0000921114 (see all company filings)

IRS No.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37544 | Film No.: 22917797
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences